35 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35126601 | Therapeutic Targets of Bufalin on Renal Carcinoma and Mechanisms: Experimental Validation of Network Pharmacology Analysis. | 2022 | 1 |
2 | 33530915 | Effect of PI3K/AKT/mTOR Signaling Pathway on Regulating and Controlling the Anti-Invasion and Metastasis of Hepatoma Cells by Bufalin. | 2021 | 2 |
3 | 34512368 | Targeting Autophagy with Natural Compounds in Cancer: A Renewed Perspective from Molecular Mechanisms to Targeted Therapy. | 2021 | 1 |
4 | 34935692 | Bufalin suppresses ovarian cancer cell proliferation via EGFR pathway. | 2021 Dec 22 | 2 |
5 | 32231716 | Anti-tumor Activity of Bufalin by Inhibiting c-MET Mediated MEK/ERK and PI3K/AKT Signaling Pathways in Gallbladder Cancer. | 2020 | 1 |
6 | 33148004 | Bufalin: A Systematic Review of Research Hotspots and Antitumor Mechanisms by Text Mining and Bioinformatics. | 2020 | 1 |
7 | 30468278 | Bufalin induces protective autophagy by Cbl-b regulating mTOR and ERK signaling pathways in gastric cancer cells. | 2019 Jan | 1 |
8 | 29568394 | Cardiac glycoside bufalin blocks cancer cell growth by inhibition of Aurora A and Aurora B activation via PI3K-Akt pathway. | 2018 Mar 2 | 1 |
9 | 29622868 | Bufalin Enhances the Cytotoxity of Human Multiple Myeloma Cells H929 to AKT Inhibitor MK2206: The Role of Protein AKT Phosphorylation. | 2018 Apr | 2 |
10 | 30128000 | Bufalin suppresses the proliferation and metastasis of renal cell carcinoma by inhibiting the PI3K/Akt/mTOR signaling pathway. | 2018 Sep | 3 |
11 | 28492559 | MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway. | 2017 May 11 | 4 |
12 | 26662961 | The effects of bufadienolides on HER2 overexpressing breast cancer cells. | 2016 Jun | 1 |
13 | 26758421 | Bufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin α2/β5/FAK signaling pathway. | 2016 Feb 23 | 1 |
14 | 26782953 | Bufalin enhances anti-angiogenic effect of sorafenib via AKT/VEGF signaling. | 2016 Mar | 2 |
15 | 26958938 | Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway. | 2016 Apr 12 | 2 |
16 | 27357249 | Bufalin reverses intrinsic and acquired drug resistance to cisplatin through the AKT signaling pathway in gastric cancer cells. | 2016 Aug | 4 |
17 | 27425252 | Inhibition of SRC-3 enhances sensitivity of human cancer cells to histone deacetylase inhibitors. | 2016 Sep 9 | 1 |
18 | 27507851 | Knockdown of Apolipoprotein E Enhanced Sensitivity of Hep3B Cells to Cardiac Steroids via Regulating Na+/K+-ATPase Signalosome. | 2016 Dec | 1 |
19 | 23949904 | Bufalin inhibits migration and invasion in human hepatocellular carcinoma SK-Hep1 cells through the inhibitions of NF-kB and matrix metalloproteinase-2/-9-signaling pathways. | 2015 Jan | 2 |
20 | 26381511 | Bufalin Reverses Resistance to Sorafenib by Inhibiting Akt Activation in Hepatocellular Carcinoma: The Role of Endoplasmic Reticulum Stress. | 2015 | 4 |
21 | 26463323 | [Bufalin reverses hepatocyte growth factor-induced resistance to afatinib in H1975 lung cancer cells]. | 2015 Jul | 2 |
22 | 26770191 | Bufalin Inhibits HCT116 Colon Cancer Cells and Its Orthotopic Xenograft Tumor in Mice Model through Genes Related to Apoptotic and PTEN/AKT Pathways. | 2015 | 1 |
23 | 24581171 | Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice. | 2014 Feb 28 | 2 |
24 | 23533466 | Bufalin Reverses HGF-Induced Resistance to EGFR-TKIs in EGFR Mutant Lung Cancer Cells via Blockage of Met/PI3k/Akt Pathway and Induction of Apoptosis. | 2013 | 2 |
25 | 23799775 | Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities. | 2013 Jul 25 | 1 |
26 | 23870199 | Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells. | 2013 Jul 19 | 2 |
27 | 24325059 | [Effect of bufalin combined gefitinib on lung cancer H1975 cells and its mechanisms research]. | 2013 Aug | 1 |
28 | 21617941 | Bufalin enhances the anti-proliferative effect of sorafenib on human hepatocellular carcinoma cells through downregulation of ERK. | 2012 Feb | 2 |
29 | 22285700 | Bufalin induces G0/G1 phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells. | 2012 Apr 1 | 1 |
30 | 22408435 | Bufalin induces lung cancer cell apoptosis via the inhibition of PI3K/Akt pathway. | 2012 | 5 |
31 | 22858649 | Bufalin increases sensitivity to AKT/mTOR-induced autophagic cell death in SK-HEP-1 human hepatocellular carcinoma cells. | 2012 Oct | 1 |
32 | 22922805 | AKT serine/threonine protein kinase modulates bufalin-triggered intrinsic pathway of apoptosis in CAL 27 human oral cancer cells. | 2012 Nov | 5 |
33 | 21181095 | Na+/K+-ATPase α3 mediates sensitivity of hepatocellular carcinoma cells to bufalin. | 2011 Mar | 1 |
34 | 20963488 | Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action. | 2010 Dec | 2 |
35 | 19343001 | PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells. | 2009 Jan | 3 |